| Dr Benjamin D Ward, MD | |
|
350 Heritage Way Ste 1200, Kalispell, MT 59901-3160 | |
| (406) 752-6784 | |
| (406) 756-4111 |
| Full Name | Dr Benjamin D Ward |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 17 Years |
| Location | 350 Heritage Way Ste 1200, Kalispell, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285839894 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 26368 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Valley Hospital | Whitefish, MT | Hospital |
| Kalispell Regional Medical Center | Kalispell, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kalispell Regional Medical Center Inc | 5294644381 | 354 |
News Archive
Children with epilepsy often face multiple challenges - not only seizures but learning, cognitive and school difficulties, side effects from medication, and, not surprisingly, social stigma from their peers.
Breast cancer, even at its initial stages, could be detected earlier and more accurately than current techniques using blood samples and a unique proteomics-based technology, according to findings of a study led by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.
Against a backdrop of growing concern about the impact of tuberculosis on children, top scientific experts today published a global plan of action for developing the vaccines that are seen as critical to eliminating the disease. Published today in a special issue of the journal, Tuberculosis , the strategic blueprint for the TB vaccine field, represents consensus reached by the TB vaccine community.
BioLineRx Ltd., a biopharmaceutical drug development company, announced today that it has signed an exclusive, worldwide license agreement with Biokine Therapeutics Ltd., a Clal Biotechnology Industries portfolio company, for the development and commercialization of BL-8040 (formerly BKT-140), a Phase II ready drug candidate for the treatment of acute myeloid leukemia (AML), as well as other types of hematological cancer.
› Verified 9 days ago
| Entity Name | Kalispell Regional Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235333139 PECOS PAC ID: 5294644381 Enrollment ID: O20031122000142 |
News Archive
Children with epilepsy often face multiple challenges - not only seizures but learning, cognitive and school difficulties, side effects from medication, and, not surprisingly, social stigma from their peers.
Breast cancer, even at its initial stages, could be detected earlier and more accurately than current techniques using blood samples and a unique proteomics-based technology, according to findings of a study led by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.
Against a backdrop of growing concern about the impact of tuberculosis on children, top scientific experts today published a global plan of action for developing the vaccines that are seen as critical to eliminating the disease. Published today in a special issue of the journal, Tuberculosis , the strategic blueprint for the TB vaccine field, represents consensus reached by the TB vaccine community.
BioLineRx Ltd., a biopharmaceutical drug development company, announced today that it has signed an exclusive, worldwide license agreement with Biokine Therapeutics Ltd., a Clal Biotechnology Industries portfolio company, for the development and commercialization of BL-8040 (formerly BKT-140), a Phase II ready drug candidate for the treatment of acute myeloid leukemia (AML), as well as other types of hematological cancer.
› Verified 9 days ago
| Entity Name | Northwest Orthopedics And Sports Medicine Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184679391 PECOS PAC ID: 1153336797 Enrollment ID: O20060217000413 |
News Archive
Children with epilepsy often face multiple challenges - not only seizures but learning, cognitive and school difficulties, side effects from medication, and, not surprisingly, social stigma from their peers.
Breast cancer, even at its initial stages, could be detected earlier and more accurately than current techniques using blood samples and a unique proteomics-based technology, according to findings of a study led by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.
Against a backdrop of growing concern about the impact of tuberculosis on children, top scientific experts today published a global plan of action for developing the vaccines that are seen as critical to eliminating the disease. Published today in a special issue of the journal, Tuberculosis , the strategic blueprint for the TB vaccine field, represents consensus reached by the TB vaccine community.
BioLineRx Ltd., a biopharmaceutical drug development company, announced today that it has signed an exclusive, worldwide license agreement with Biokine Therapeutics Ltd., a Clal Biotechnology Industries portfolio company, for the development and commercialization of BL-8040 (formerly BKT-140), a Phase II ready drug candidate for the treatment of acute myeloid leukemia (AML), as well as other types of hematological cancer.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Benjamin D Ward, MD 350 Heritage Way Ste 1200, Kalispell, MT 59901-3160 Ph: (406) 752-6784 | Dr Benjamin D Ward, MD 350 Heritage Way Ste 1200, Kalispell, MT 59901-3160 Ph: (406) 752-6784 |
News Archive
Children with epilepsy often face multiple challenges - not only seizures but learning, cognitive and school difficulties, side effects from medication, and, not surprisingly, social stigma from their peers.
Breast cancer, even at its initial stages, could be detected earlier and more accurately than current techniques using blood samples and a unique proteomics-based technology, according to findings of a study led by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.
Against a backdrop of growing concern about the impact of tuberculosis on children, top scientific experts today published a global plan of action for developing the vaccines that are seen as critical to eliminating the disease. Published today in a special issue of the journal, Tuberculosis , the strategic blueprint for the TB vaccine field, represents consensus reached by the TB vaccine community.
BioLineRx Ltd., a biopharmaceutical drug development company, announced today that it has signed an exclusive, worldwide license agreement with Biokine Therapeutics Ltd., a Clal Biotechnology Industries portfolio company, for the development and commercialization of BL-8040 (formerly BKT-140), a Phase II ready drug candidate for the treatment of acute myeloid leukemia (AML), as well as other types of hematological cancer.
› Verified 9 days ago
Lawrence John Iwersen, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 111 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-752-7900 Fax: 406-257-0253 | |
Parley Kurt Thorderson, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 350 Heritage Way, Suite 1200, Kalispell, MT 59901 Phone: 406-752-6784 Fax: 406-756-4111 | |
Kim D Stimpson, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 350 Heritage Way, Suite 1200, Kalispell, MT 59901 Phone: 406-752-6784 Fax: 406-756-4111 | |
Dr. Joseph Henry Bergman, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 111 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-752-7900 | |
Albert David Olszewski, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 111 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-752-7900 Fax: 406-257-0253 | |
Nathaniel Wilcox Fogel, MD, MS Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 350 Heritage Way Ste 1200, Kalispell, MT 59901 Phone: 406-752-6784 Fax: 406-756-4111 |